Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
The Mission Marketing Group Plc LSE:TMMG London Ordinary Share GB00B11FD453 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 78.50 77.00 80.00 - 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 159.9 11.0 10.9 7.2 67

The Mission Marketing Share Discussion Threads

Showing 851 to 875 of 1450 messages
Chat Pages: Latest  46  45  44  43  42  41  40  39  38  37  36  35  Older
DateSubjectAuthorDiscuss
27/1/2015
07:06
Glasshalffull, Here also :-) Excellant summary. Bought back in yesterday morning after holding last year. Bought primarily for some of reasons you mentioned....reducing dept combined with conservative PE and low PEG.
jakedog2
26/1/2015
22:40
Just myself and janeann here? Only 2 posts today despite release of their trading update & astonishingly we posted at exactly the same time :-) finnCap have reiterated their Buy rating here and 60p price target. As mentioned 5.0p EPS estimated for 2014 which is forecasted to rise by 13% to 5.7p EPS this year...for 2015 PER of only 7.3 Today's trading update implies that TMMG have achieved c.£5.5m PBT...& therefore a v strong H2 where they would have delivered close to £3.7m PBT vs £1.8m in H1. Net debt is also forecast to reduce to £7.0m at 2014 year end. This is the kicker for me here & has occurred solely as a result of strong cashflow (with exception of 2 x small placing's for £1.2m in 2012 & £2.4m in 2014, proceeds utilised for acquisitions in both cases). Net debt has been reduced as follows:- Net Debt (at Yr end) 2009 -(£20.6m) 2010 -(£18.6m) 2011 -(£15.4m) 2012 -(£12.5m) 2013 -(£10.8m) 2014 -(£7.0m) 2015 dividend yield now approaching 3% for this year (est. 2.86%) Also worth mentioning that TMMG released a RNSON in December 2014 showcasing the multiple awards their businesses had won. In conclusion, they look an excellent risk/reward play in the marketing arena, low PER with improving b/s, dividend yield and low PEG of 0.56 ... Oh, and 2014 figures will mark 5-yrs of normalised EPS growth. Regards, GHF
glasshalfull
26/1/2015
07:28
short and very acceptable... The Mission Marketing Group plc ('the missiontm', AIM: TMMG), the marketing communications and advertising group, today issued the following trading update for the year ended 31 December 2014. We are pleased to report that, following a strong second half, we expect to be in line with market expectations for the year ended 31 December 2014. We also expect our year-on-year net bank debt, gearing ratio and debt leverage ratio to be further reduced. We expect to announce our preliminary results on 26 March 2015 and look forward to further progress in 2015
janeann
26/1/2015
07:28
As forecast on 19/01/15...TMMG have today confirmed strong trading in H2 2014 & that results will be in line with 5p EPS forecasts with debt lower. Pleasingly they are forecasting further growth in 2015 @Glasshalfull1: TMMG (Mission Marketing) Positive t/s confirming in line results. PER 8, 2.6% yield & strong outlook for 2015 Http://t.co/atuO7UdyLr #TMFPP Well done to TMMG management & employees! Regards GHF
glasshalfull
20/1/2015
09:25
Thanks for highlighting GHF :-)
cheshire man
19/1/2015
16:59
Last year we had an IMS on 21/1 so I guess we could be getting one soon.
dr biotech
19/1/2015
15:48
I love quiet threads :-) Per my tweet:- @Glasshalfull1: TMMG (Mission Marketing) 4yrs norm. EPS growth & look good value with shareprice down 18% since Nov. PER only 8 with 2.7% div yield #TMFPP Needless to say, I've been buying... Regards GHF
glasshalfull
19/11/2014
16:13
This is from the Naked trader website. Not sure if many follow it, may explain the movement last week (article is date Nov 12) Mission Marketing (LON:TMMG) looks like a share with plenty of decent upside to come, I'm reckoning there is 25% upside to be had. It's buying up other companies it its space, which should gradually enhance earnings and it looks very cheap. Its statements are bullish and it easily raised last month another 2.5 to spend on acquisitions. Looks like some good management here so a confident buy for me, the trade made live in Mission at the seminar last week.
dr biotech
13/11/2014
15:55
50p just been paid. f
fillipe
11/11/2014
22:19
For those that have not seen (heard) this http://www.brrmedia.co.uk/event/132314/partner/lse
red_shed2000
11/11/2014
09:43
Thanks for that 18BT. Must admit I am sceptical of brokers at the best of times and paid for research such as that provided by Edison I rank as even worse. The article continues The continuation of tough markets and poor visibility make forecasting in the sector more than usually unreliable. However, it is clear that there will be no early recovery in client spend and unlikely that there will be a lessening of margin pressure short-term, although we do anticipate conditions easing in 2010. The smaller marketing services companies have been hard hit and are now trading at an average of 5.5x earnings, compared to WPP at 8.9x current year. Last updated on 03/11/2014 They used to cover TMMG in 2009 (restarted about a year ago) - can't help but think the 2010 date is a cut and paste error. Having said that I feel this share is somewhat undervalued and is my biggest small cap play. Though some of my large caps are becoming small caps....
dr biotech
11/11/2014
07:06
New report from Edison following the acquisition yesterday: The mission is continuing its acquisition programme to build up its capabilities and resource. It has today added to its PR activities with the purchase of Speed Communications. Although a small transaction,including the issue of 600,000 shares, this gives the group greater resource, a wider range of vertical speciality and further strengthens the client roster. Afterlast month’s share placing and acquisition in Singapore, the group is clearly confident and back in growth mode, and is back on the dividend list. The share price has yet to reflect this transition.
18bt
09/10/2014
08:52
Taken some more here. They're bound to get a decent write-up in the likes of IC etc after their recent RNS and the Edison "Quickview" comment, I feel. f
fillipe
07/10/2014
13:25
Well looks like someone knew the placing was coming ...
18bt
07/10/2014
10:58
Placing was a bit of a surprise this morning. At least they placed them at a premium.
dr biotech
25/9/2014
10:53
I can see what you mean - but profits are more biased towards 2nd half even though income is roughly the same. I guess a lot of ad space/time has been bought forward So I am hopeful FY could be near 6m this year. Figures are 6months 2014/ 6 months 2013/FT2013. OPERATING INCOME 26,290 25,370 51,594 Headline operating expenses (24,191) (23,325) (45,877) HEADLINE OPERATING PROFIT 2,099 2,045 5,717
dr biotech
25/9/2014
10:25
Hi dr b, I was looking at the operating income line, for which h1 last year was £25m and h2 £26m.
sundance 13
25/9/2014
10:05
What figures are you using? Last year was split 2:3 between the first 6 months and the second. So the second half was 50% higher. There were particular reasons for this last year as they lost a key customer in H1 - for them to have improved modestly on last years H1 shows they have overcome that loss. If they repeat last years H2 (3m) that would give just over 5m for the year and a PE of less about 8.
dr biotech
25/9/2014
09:48
Puku, what 2nd half bias? When u check last years results there isn't really any discernible difference between halves.
sundance 13
25/9/2014
09:14
I am keeping mine - new offices doing well, several big new clients, second half bias - brokers were already forecasting 5p and my guess is for more than that, leading to a P/E well below 10. Might top up.
puku
25/9/2014
08:29
think the management here have done a great job over last few years, but kicking on from here will prove IMO more challenging....as you say and I have invested in, there are other opportunities in this sector with a better yield and growth prospects such as Cello and Creston...
qs99
25/9/2014
07:17
Yeah not all that impressed with results, trading looks largely flat with a slight increase in operating income offset by an increase in operating costs. All this h2 bias stuff just looks like an excuse to defer the words 'profit warning' for a bit longer in the hope things pick up more.Rating looks about right to me if they come in at around 4.5p eps, which would be below market expectations but in line with h1 performance.PE around 11 looks about right considering lack of growth, I've sold my smallish holding this morning, better opportunities elsewhere.
sundance 13
25/9/2014
07:17
Sold my small holding this morning but as ever GLA.
battlebus2
25/9/2014
07:07
I agree sundance, looks like risks on H2 may outweigh potential upside IMO in terms of how far the shares have come. Until they deliver that i'm on the sidelines...much better value and yield and upside potential IMO in CRE and CLL...
qs99
25/9/2014
06:58
Going down as far as operating income I'm struggling to see much of the historic 2nd half bias they mention?? Looked like it was marginally higher in the 2nd half last year versus H1, but hardly by a meaningful amount?What am I missing?
sundance 13
Chat Pages: Latest  46  45  44  43  42  41  40  39  38  37  36  35  Older
ADVFN Advertorial
Your Recent History
LSE
TMMG
The Missio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201025 06:14:46